Answers are grounded in this paper and cite their sources.
This innovative device demonstrates physiological modulation via sensing and controlled drug release, highlighting potential for type II diabetes management and neurotransmitter modulation.
Intelligent wearable devices with integrated sensing and drug-releasing functions are essential for delivering real-time and personalized interventions. Current approaches typically rely on interconnected modules, facing challenges such as large footprint, high energy consumption, and fabrication complexity. To address these limitations, we introduce a modified organic electrochemical transistor structure called the organic electrochemical transceiver (OECTC). The OECTC leverages the electronic wettability switch characteristic of conjugated polymers to convert sensed signals into a valve mechanism for controlling the release of chemical substances (e.g., drugs and neurotransmitters). This provides an all-in-one solution for synchronized signal recording and substance release for physiological modulation. The applications of the OECTC in intelligent wearable devices for managing type II diabetes and as a neural amplifier or inverter for neurotransmitter modulation are demonstrated.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: